NASDAQ: CBUSCibus Inc Stock Ownership - Who owns Cibus?
Insider buying vs selling
Have Cibus Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gregory Francis William Gocal | Chief Scientific Officer EVP | 2024-07-15 | 2,000 | $10.01 | $20.02kSell |
| Gregory Francis William Gocal | Chief Scientific Officer EVP | 2024-07-12 | 2,000 | $10.00 | $20.00kSell |
| Gregory Francis William Gocal | Chief Scientific Officer EVP | 2024-06-27 | 2,000 | $10.00 | $20.00kSell |
| Rory B. Riggs | Chief Executive Officer | 2024-06-11 | 98,040 | $10.20 | $1.00MBuy |
| Rory B. Riggs | Chief Executive Officer | 2023-12-12 | 517,107 | $10.58 | $5.47MBuy |
CBUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CBUS insiders and whales buy or sell their stock.
CBUS Shareholders
What type of owners hold Cibus Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sa Cellectis | 91.46% | 23,963,175 | $125.81M | Insider |
| Rory B. Riggs | 16.64% | 4,359,998 | $22.89M | Insider |
| Fmr LLC | 12.77% | 3,346,951 | $17.57M | Institution |
| Jeanpierre Jules Lehmann | 6.74% | 1,764,928 | $9.27M | Insider |
| Mark Terrence Finn | 5.90% | 1,544,711 | $8.11M | Insider |
| Jonathan Finn | 5.80% | 1,519,221 | $7.98M | Insider |
| Vantage Consulting Group Inc | 4.37% | 1,143,949 | $6.01M | Institution |
| Blackrock Inc | 3.77% | 986,632 | $5.18M | Institution |
| Vanguard Group Inc | 3.09% | 810,868 | $4.26M | Institution |
| Armistice Capital LLC | 1.97% | 516,000 | $2.71M | Institution |
CBUS vs Biotech Stocks
Cibus Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.